# OnCo record nct03414658 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03414658/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03414658", "NCT03414658" ;
  schema:name "AVIATOR"@en ;
  schema:alternateName "The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer"@en ;
  schema:description "AVIATOR compares trastuzumab and vinorelbine with combinations that add avelumab, with or without utomilumab. It asks whether the added immune treatments improve control of advanced HER2-positive breast cancer."@en ;
  schema:url <https://onco.cc/trials/nct03414658/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03414658>, <https://clinicaltrials.ucsf.edu/trial/NCT03414658> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2018-06-21" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/avelumab/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/utomilumab/>, <https://onco.cc/drugs/vinorelbine/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .